BRPI0413545A - composições farmacêuticas - Google Patents

composições farmacêuticas

Info

Publication number
BRPI0413545A
BRPI0413545A BRPI0413545-8A BRPI0413545A BRPI0413545A BR PI0413545 A BRPI0413545 A BR PI0413545A BR PI0413545 A BRPI0413545 A BR PI0413545A BR PI0413545 A BRPI0413545 A BR PI0413545A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
lavendustine
emollient
methoxy
emulsion
Prior art date
Application number
BRPI0413545-8A
Other languages
English (en)
Inventor
Katrin Kriwet
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0413545A publication Critical patent/BRPI0413545A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçõES FARMACêUTICAS". A presente invenção refere-se a composições farmacêuticas tópicas, por exemplo, na forma de uma emulsão, que compreendem um derivado de lavendustina de fórmula (I); onde R é metila, metóxi ou etila, ou um sal farmaceuticamente aceitável destas, e um emoliente, e opcionalmente excipientes adicionais.
BRPI0413545-8A 2003-08-19 2004-08-18 composições farmacêuticas BRPI0413545A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0319497.4A GB0319497D0 (en) 2003-08-19 2003-08-19 Organic compounds
PCT/EP2004/009273 WO2005016322A2 (en) 2003-08-19 2004-08-18 Pharmaceutical compositions of lavendustin

Publications (1)

Publication Number Publication Date
BRPI0413545A true BRPI0413545A (pt) 2006-10-17

Family

ID=28052795

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0413545-8A BRPI0413545A (pt) 2003-08-19 2004-08-18 composições farmacêuticas

Country Status (18)

Country Link
US (2) US20060205746A1 (pt)
EP (1) EP1675621B1 (pt)
JP (1) JP2007502799A (pt)
CN (1) CN100490899C (pt)
AT (1) ATE355084T1 (pt)
AU (1) AU2004264680B2 (pt)
BR (1) BRPI0413545A (pt)
CA (1) CA2534492A1 (pt)
CY (1) CY1106510T1 (pt)
DE (1) DE602004005064T2 (pt)
DK (1) DK1675621T3 (pt)
ES (1) ES2280045T3 (pt)
GB (1) GB0319497D0 (pt)
MX (1) MXPA06001886A (pt)
PL (1) PL1675621T3 (pt)
PT (1) PT1675621E (pt)
SI (1) SI1675621T1 (pt)
WO (1) WO2005016322A2 (pt)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06312919A (ja) * 1993-05-06 1994-11-08 Kao Corp 美白剤及びこれを含有する皮膚化粧料
RU2164224C2 (ru) * 1995-03-14 2001-03-20 Новартис Аг Трехзамещенные фенильные производные и фармацевтическая композиция
TWI234455B (en) * 1998-04-02 2005-06-21 Univ Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
US6965375B1 (en) * 2001-04-27 2005-11-15 Palm, Inc. Compact integrated touch panel display for a handheld device
US7656393B2 (en) * 2005-03-04 2010-02-02 Apple Inc. Electronic device having display and surrounding touch sensitive bezel for user interface and control
US6919678B2 (en) * 2002-09-03 2005-07-19 Bloomberg Lp Bezel-less electric display

Also Published As

Publication number Publication date
SI1675621T1 (sl) 2007-08-31
PT1675621E (pt) 2007-05-31
CN100490899C (zh) 2009-05-27
AU2004264680B2 (en) 2007-09-27
DE602004005064T2 (de) 2007-07-12
DK1675621T3 (da) 2007-05-21
PL1675621T3 (pl) 2007-06-29
CA2534492A1 (en) 2005-02-24
ES2280045T3 (es) 2007-09-01
EP1675621A2 (en) 2006-07-05
CY1106510T1 (el) 2012-01-25
DE602004005064D1 (de) 2007-04-12
WO2005016322A2 (en) 2005-02-24
US20060205746A1 (en) 2006-09-14
WO2005016322A3 (en) 2005-11-03
ATE355084T1 (de) 2006-03-15
MXPA06001886A (es) 2006-05-17
EP1675621B1 (en) 2007-02-28
GB0319497D0 (en) 2003-09-17
CN1835770A (zh) 2006-09-20
HK1092699A1 (en) 2007-02-16
AU2004264680A1 (en) 2005-02-24
US20080242686A1 (en) 2008-10-02
JP2007502799A (ja) 2007-02-15

Similar Documents

Publication Publication Date Title
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
ECSP024399A (es) Derivados de benzotiazol
PA8547701A1 (es) Nucleosidos 4 substituidos.
BR0115411A (pt) Combinações sinergìsticas compreendendo um inibidor de renina para doenças cardiovasculares
BRPI0714908B8 (pt) derivados de pirimidina como inibidor de pi3k, composição farmacêutica e agente preventivo ou agente terapêutico de uma doença proliferativa que os compreende
BRPI0508833A (pt) formulações galênicas de compostos orgánicos
BR0312729A (pt) Novos derivados de indol-3-enxofre
BRPI0511504A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, e, agente preventivo ou terapêutico para uma doença resultante de beta-amilóides
BR0210028A (pt) Agentes antibacterianos
BR0012697A (pt) Inibidores da diferenciação de th2
BR0010520A (pt) Novos compostos farmaceuticamente ativos
BRPI0407097A (pt) Antagonista do casr
BRPI0706992C1 (pt) composto de fórmula (i) e formulação farmacêutica
BRPI0415053B8 (pt) inibidor de glicoproteína-p, método para preparar o mesmo e composição farmacêutica que compreende o mesmo
BRPI0518231A2 (pt) derivados de 2-amido-4-feniltiazol, o respectivo preparo e a respectiva aplicaÇço em terapÊutica
BR0113590A (pt) 7-oxo-piridopirimidinas
BRPI0518993A2 (pt) composto ou um sal, solvato ou Éster farmaceuticamente aceitÁvel do mesmo, composiÇço farmacÊutica, e, uso de um composto
YU86701A (sh) Jedinjenja i formulacije za inhibiciju agregacije proteina i snimanje amiloidnih naslaga
BRPI0413384A (pt) inibidores da proteìna farnesil transferase como agentes antitumores
CR7956A (es) Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos
AR043253A1 (es) 4-[(2,4-dicloro-5-metoxifenil)amino] -6- alcoxi-3-quinolina carbonitrilos para el tratamiento de lesiones isquemicas
BRPI0412239A (pt) sistemas emulsificantes contendo derivados de azetidina
BR0317693A (pt) Derivados de epotilona
BRPI0519764A2 (pt) composiÇÕes farmacÊuticas derivadas de Ácido xanturÊnico e mÉtodos relacionados a estas
BRPI0413545A (pt) composições farmacêuticas

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. A61K 47/44, 47/14, 47/10, 47/06, 31/195; A61P 35/00, 17/00

Ipc: A61K 47/44 (2011.01), A61K 47/14 (2011.01), A61K 4

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.